COVID-19 antiviral treatment: Molnupiravir
Information for those who have been prescribed Molnupiravir.
Documents
Details
The NHS is offering new antibody and antiviral treatments to people with coronavirus (COVID-19) who are at highest risk of becoming seriously ill.
This document includes information for those who have been prescribed Molnupiravir including how long to take the medicines for, what to do if you are pregnant or breastfeeding, and how to report side effects.
Paper copies of this leaflet are available free to order or download in the following languages:
English, Albanian, Arabic, Bengali, Bulgarian, Chinese (simplified), Chinese (traditional, Cantonese), Estonian, Farsi, French, Greek, Gujarati, Hindi, Latvian, Lithuanian, Panjabi, Pashto, Polish, Portuguese, Romanian, Romany, Russian, Somali, Spanish, Tagalog, Turkish, Twi, Ukrainian, Urdu and Yiddish.
An English large print version is available to order.
A Braille version of this leaflet is available to order.
An audio version of this leaflet is available to download.
A British sign language (BSL) video of this guide is available to view or download.
Health publications orderline
Immunisation Publications
UK Health Security Agency, 61 Colindale Avenue, Colindale
London
NW9 5EQ
Contact form https://www.healthpubl...
Telephone: 0300 123 1002
Copies of printed publications and the full range of digital resources to support the immunisation programmes can now be ordered and downloaded online. Log in to register and place your order.
Updates to this page
Published 11 February 2022Last updated 4 May 2022 + show all updates
-
Added links to translations and alternative formats.
-
Added British Sign Language video link.
-
First published.